The emergence of the novel coronavirus, SARS-CoV-2, and its associated disease, COVID-19, has posed unprecedented challenges to global public health. Despite widespread vaccination efforts and the development of antiviral drugs, the COVID-19 pandemic continues to spread, emphasizing the need for alternative preventive and therapeutic approaches [1-2]. Dietary plant extracts have long been recognized for their potential health benefits, including antimicrobial and antiviral properties. In recent years, there has been growing interest in exploring the antiviral effects of dietary plant extracts against SARS-CoV-2 [3-4]. This comprehensive review aims to examine the current evidence on the preventive potential of dietary plant extracts against SARS-CoV-2 infection.

The COVID-19 pandemic, caused by the novel coronavirus SARS-CoV-2, has posed unprecedented global health challenges, prompting an urgent search for effective antiviral treatments [5]. While vaccines have played a pivotal role in mitigating the spread of the virus, the development of therapeutic interventions remains crucial, particularly in managing severe cases and emerging variants. Amidst this landscape, natural products derived from dietary plant extracts have garnered attention for their potential antiviral properties.

Dietary plant extracts are rich sources of bioactive compounds known for their diverse pharmacological activities, including antiviral effects against a range of pathogens [6]. Historically, plants have been integral to traditional medicine systems worldwide, providing remedies for various ailments. Recent advancements in scientific research have elucidated the mechanisms by which plant-derived compounds interact with viral pathogens, inhibiting viral entry, replication, and dissemination within host cells. This introduction sets the stage for a comprehensive exploration of the antiviral properties of dietary plant extracts against SARS-CoV-2. It outlines the rationale for investigating natural products as potential therapeutics, highlighting their accessibility, safety profile, and potential synergies with conventional treatments [7]. Furthermore, it underscores the need for systematic evaluation through rigorous scientific inquiry, encompassing in vitro experiments, animal models, and clinical trials. In addressing the current gaps in knowledge and navigating the complexities of natural product research, this review aims to consolidate existing evidence and provide insights into the feasibility and efficacy of dietary plant extracts as antiviral agents [8-9]. By elucidating their mechanisms of action, assessing their therapeutic potential, and discussing challenges in translation to clinical practice, this review seeks to inform future research directions and contribute to the development of novel strategies in combating COVID-19 and future viral threats.

Mechanisms of Action

Dietary plant extracts exhibit a wide range of bioactive compounds, including polyphenols, flavonoids, terpenoids, alkaloids, and essential oils, which possess diverse antiviral activities [10-11]. These compounds can target various stages of the viral replication cycle, including viral entry, replication, assembly, and release. For instance, certain polyphenols and flavonoids have been shown to inhibit viral attachment and entry into host cells by blocking viral spike protein interactions with cellular receptors. Other compounds, such as terpenoids and alkaloids, interfere with viral replication machinery or modulate host immune responses to suppress viral spread [6]. Additionally, essential oils derived from aromatic plants exhibit direct virucidal effects by disrupting viral envelopes or capsids, thereby preventing viral entry and infectivity.

Preclinical and Clinical Evidence

 A growing body of preclinical studies has demonstrated the antiviral effects of dietary plant extracts against SARS-CoV-2 and related coronaviruses in cell culture and animal models. These studies have shown that treatment with plant extracts can reduce viral replication, inhibit cytopathic effects, and modulate host immune responses to enhance antiviral defense mechanisms [12-13]. Furthermore, several clinical trials have investigated the efficacy of dietary plant extracts as preventive or adjunctive therapies for COVID-19. Although preliminary findings are promising, larger-scale clinical trials are needed to confirm the safety and efficacy of these extracts in human populations.

Potential Applications

Dietary plant extracts offer potential applications as natural antiviral agents for preventing SARS-CoV-2 infection and reducing viral transmission. These extracts can be incorporated into various formulations, including dietary supplements, functional foods, herbal teas, and topical preparations, to enhance antiviral efficacy and promote immune health [14-18]. Furthermore, dietary plant extracts can complement existing preventive strategies, such as vaccination and hygiene measures, by providing additional layers of protection against viral infections. However, challenges remain in standardizing extract formulations, optimizing dosing regimens, and ensuring product quality and safety for widespread use.

Challenges and Future Directions

 Despite the promising potential of dietary plant extracts as antiviral agents, several challenges need to be addressed to facilitate their translation into clinical practice [19-24]. These include elucidating the mechanisms of action of bioactive compounds, conducting rigorous preclinical and clinical studies, optimizing extraction and formulation techniques, and addressing regulatory and safety concerns. Future research directions may focus on identifying synergistic combinations of plant extracts, exploring novel delivery systems, and integrating traditional knowledge with modern scientific approaches to develop effective antiviral interventions.

Conclusion

Dietary plant extracts represent a promising source of natural antiviral agents for preventing SARS-CoV-2 infection and mitigating the spread of COVID-19. With their diverse bioactive compounds and mechanisms of action, these extracts offer potential therapeutic benefits against viral pathogens, including SARS-CoV-2. However, further research is needed to elucidate their efficacy, safety, and optimal use in clinical settings. By harnessing the preventive potential of dietary plant extracts, we can complement existing strategies and strengthen global efforts to control the COVID-19 pandemic.

References

1. Alabdullatif, M., & Hemida, M. G. (2021). Evaluation of antiviral activity of aqueous extract of Zingiber officinale rhizome against SARS-CoV-2. Biomed Research International, 2021, 5590876.
2. Bhuiyan, F. R., Howlader, S., Raihan, T., Hasan, M., & Phoolcharoen, W. (2020). Plant-based phytochemical screening by targeting main protease of SARS-CoV-2: an approach to mitigate COVID-19 pandemic. Journal of Biomolecular Structure and Dynamics, 1-15.
3. Chojnacka, K., Witek-Krowiak, A., Skrzypczak, D., & Mikula, K. (2020). Phytochemicals containing biologically active polyphenols as an effective agent against COVID-19-inducing coronavirus. Journal of Functional Foods, 73, 104146.
4. Elgazwi, M. A., Elhassan Taha, M. M., & Zgheel, F. (2021). The medicinal plants and phytochemicals as promising strategies to combat coronaviruses including COVID-19: A review. Current Pharmaceutical Biotechnology, 22(5), 590-601.
5. Gendrot, M., Andreani, J., Boxberger, M., Jardot, P., Fonta, I., Le Bideau, M., … & Mosnier, J. (2020). Antimalarial artemisinin-based combination therapies (ACT) and COVID-19 in Africa: In vitro inhibition of SARS-CoV-2 replication by mefloquine-artesunate. International Journal of Infectious Diseases, 99, 437-440.
6. Khan, S. A., Zia, K., Ashraf, S., Uddin, R., & Ul-Haq, Z. (2020). Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2 via integrated computational approach. Journal of Biomolecular Structure and Dynamics, 1-10.
7. Kumar, D., Kumari, K., Jayaraj, A., Kumar, V., Kumar, R. V., Dass, S. K.,& Singh, P. (2021). Understanding the binding affinity of noscapines with protease of SARS-CoV-2 for COVID-19 using MD simulations at different temperatures. Journal of Biomolecular Structure and Dynamics, 1-12.
8. Lam, T. T., Jia, N., Zhang, Y. W., Shum, M. H., Jiang, J. F., Zhu, H. C., … & Cao, W. C. (2020). Identifying SARS-CoV-2-related coronaviruses in Malayan pangolins. Nature, 583(7815), 282-285.
9. Nascimento, M. S. S., Franco, M. C., Borges, B. C., Lima, J. A., Andrade, E. H. A., & Maia, J. G. S. (2021). Composition and antiviral activity of essential oil from leaves of Pimenta dioica and its nanoemulsion form. Industrial Crops and Products, 164, 113393.
10. Padhi, A. K., Shukla, R., & Tripathi, T. (2020). Triazoles as potential inhibitors of SARS-CoV-2 main protease: a molecular docking and simulation studies. Journal of Biomolecular Structure and Dynamics, 1-11.
11. Pandey, P., Rane, J. S., Chatterjee, A., Kumar, A., & Khan, R. (2020). Targeting SARS-CoV-2 spike protein of COVID-19 with naturally occurring phytochemicals: an in silico study for drug development. Journal of Biomolecular Structure and Dynamics, 1-16.
12. Prompetchara, E., Ketloy, C., & Palaga, T. (2020). Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic. Asian Pacific Journal of Allergy and Immunology, 38(1), 1-9.
13. Sagar, S., Kaur, M., & Minneman, K. P. (2020). Antiviral lead compounds from marine sponges. Marine Drugs, 18(1), 43.
14. Shree, P., Mishra, P., Selvaraj, C., Singh, S. K., Chaube, R., Garg, N., … & Mondal, R. K. (2020). Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants–Withania somnifera (Ashwagandha), Tinospora cordifolia (Giloy) and Ocimum sanctum (Tulsi)–A molecular docking study. Journal of Biomolecular Structure and Dynamics, 1-14.
15. Solnier, J., Fladerer, J. P., Flavell, S., Granet, R., & Morre, M. (2021). Potential inhibition of SARS-CoV-2 main protease by steroidal molecules: Drug repurposing strategy. Heliyon, 7(1), e05943.
16. Tiwari, R., Dhama, K., Sharun, K., Iqbal Yatoo, M., Malik, Y. S., Singh, R.,& Harapan, H. (2020). COVID-19: animals, veterinary and zoonotic links. Veterinary Quarterly, 40(1), 169-182
17. Tortorici, M. A., & Veesler, D. (2019). Structural insights into coronavirus entry. Advances in Virus Research, 105, 93-116.
18. Ul Qamar, M. T., Alqahtani, S. M., Alamri, M. A., & Chen, L. L. (2020). Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants. Journal of Pharmaceutical Analysis, 10(4), 313-319.
19. Vellingiri, B., Jayaramayya, K., Iyer, M., Narayanasamy, A., Govindasamy, V., Giridharan, B., … & Rajagopalan, K. (2020). COVID-19: A promising cure for the global panic. Science of the Total Environment, 725, 138277.
20. Xu, Z., Peng, C., Shi, Y., Zhu, Z., Mu, K., Wang, X., … & Zhu, W. (2020). Nelfinavir was predicted to be a potential inhibitor of 2019-nCov main protease by an integrative approach combining homology modelling, molecular docking and binding free energy calculation. BioRxiv.
21. Yan, R., Zhang, Y., Li, Y., Xia, L., Guo, Y., & Zhou, Q. (2020). Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science, 367(6485), 1444-1448.
22. Yang, Y., Islam, M. S., Wang, J., Li, Y., & Chen, X. (2021). Traditional Chinese medicine in the treatment of patients infected with 2019-new coronavirus (SARS-CoV-2): A review and perspective. International Journal of Biological Sciences, 17(8), 2323.
23. Zhang, R., Wang, X., Ni, L., Di, X., Ma, B., Niu, S., … & Jiang, W. (2020). COVID-19: Melatonin as a potential adjuvant treatment. Life Sciences, 250, 117583.
24. Zhao, H., Zhou, J., Zhang, K., Chu, H., Liu, D., Poon, V. K., … & Zheng, B. J. (2016). A novel peptide with potent and broad-spectrum antiviral activities against multiple respiratory viruses. Scientific Reports, 6, 22008.